AIF Capital invests in Indian pharmaceutical company

The Hong Kong firm has backed Bangalore-based BioPlus Life Sciences with an investment of $31m from its third Asian fund.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this